AMANDA WOODWARD: Open Payments
NPI 1467077990 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,782 in 75 payments from 35 companies in 2025. Trend: 2023 $997 · 2024 $1,975 · 2025 $1,782
Food & beverage: $1,665Education: $117
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 10 | $314 |
| Novartis Pharmaceuticals Corporation | 5 | $135 |
| ABBVIE INC. | 6 | $133 |
| GlaxoSmithKline, LLC. | 6 | $119 |
| Janssen Biotech, Inc. | 5 | $114 |
| Merck Sharp & Dohme LLC | 3 | $72 |
| BeOne Medicines USA, Inc. | 3 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| PFIZER INC. | 3 | $68 |
| Incyte Corporation | 2 | $49 |
Products named: Enhertu, VENCLEXTA, KISQALI, RYBREVANT, KEYTRUDA, Nubeqa, IBRANCE, JEMPERLI.
Industry payments across GA — which companies pay providers there.
